Healthcare utilization and costs associated with changes in medication adherence around the 80% threshold in patients with cardiovascular disease

Read full text Summarise with VIRAT
Authors: Samuel K. Peasah, Tiffany Lee, Yan Huang, Angela Inneh, Urvashi Patel, Chester B. Good
Cited by: 0
References: 15

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Health care utilization and cost impacts, of medication adherence above or below the 80% threshold, remains unclear for cardiometabolic medications. OBJECTIVE: To evaluate the differences in cardiovascular-related emergency department (ED) visits and total cost-of-care associated with changes in medication adherence around the 80% threshold. METHODS: Retrospective observational analysis of claims spanning from Jan 1, 2021, to June 30, 2023. Patients aged 50-80 years with a history of cardiovascular disease and specific cardiometabolic medications were followed for 12 months, and prepost index-fill outcomes compared. Patients were categorized into pre- and postindex groups: 3 pre-index groups (Pre1-moderate, Pre2-high, Pre3-very-high) based on their pre-index 12-month adherence [postindex adherence (PDC)] and 4 post-index groups based on postindex PDC (Post0-low, Post1-moderate, Post2-high, Post3-very-high), for 4 medication classes (antidiabetics, direct oral coagulants [DOACs], antiplatelets, and antiheart-failure meds [HF]). Group definitions: Post0-low (PDC ≤ 69%), Pre1-moderate or Post1-moderate (PDC 70-

Fields of Study & Subjects

Medication Adherence and Compliance Atrial Fibrillation Management and Outcomes Pharmaceutical Practices and Patient Outcomes

Publication details

Journal / source
Journal of the American Pharmacists Association
Volume
66
Issue
3
Pages
103104–103104
Publication date
25 March 2026
Language
EN